Xvivo Perfusion AB (publ) carries a market capitalization of 224.55M, placing it among publicly traded companies globally.
| Market Cap | 224.55M |
| Enterprise Value | N/A |
Xvivo Perfusion AB (publ)'s stock has gained approximately 25.06667% over the past 52 weeks. The 50-day moving average sits at 5.27, while the 200-day moving average is 5.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | 25.06667% |
| 50-Day Moving Average | 5.27 |
| 200-Day Moving Average | 5.27 |
| Average Volume (20 Days) | N/A |